Howard Colman

19PUBLICATIONS

167CO-AUTHORS

Molecular targetsBiological adaptationRegenerative medicine (incl. stem cells)Mining, energy and natural resources lawTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|May 22, 2026

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Apr 24, 2026

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

|Apr 14, 2026

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Dec 15, 2025

Stereotactic radiosurgery for radiation‑induced meningiomas: long‑term institutional outcomes with patient- and lesion‑level analyses and an updated meta‑analysis.

Saachi Jhandi, Angad S Jhandi, Donald M Cannon

|Dec 01, 2025

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Dec 30, 2024

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.

Joe S Mendez, Adam L Cohen, Midori Eckenstein

Pageof 4

Frequent Collaborators

Patrick Y Wen

Tobias Walbert

Randy L Jensen

L Burt Nabors

Michael Weller

Eudocia Q Lee

Adam L Cohen

David A Reardon

David Schiff

Priya Kumthekar

Frequent Collaborators

Patrick Y Wen

Tobias Walbert

Randy L Jensen

L Burt Nabors